|
⚲
|
| Keyboard |
| Gorman Kevin Charles
✚
|
|
|---|---|
| CIK # | 0001201096 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001201096] | |
| 4 | [0001201096] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gorman Kevin Charles | |
| Xencor Inc | |
| Neurocrine Biosciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Grant | 63,724 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 34,380 | $124.12 | 4,267,246 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 2,901 | $124.12 | 360,072 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Option exercise | 5,604 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 3,024 | $124.12 | 375,339 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Option exercise | 5,377 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Option exercise | 5,377 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Option exercise | 5,604 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-01-31 | Option exercise | 5,142 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-01-31 | Option exercise | 5,142 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-01-31 | Tax withheld | 2,845 | $136.06 | 387,091 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2025-08-07 | Option exercise | 106,322 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-08-07 | Option exercise | 106,322 | $35.99 | 3,826,529 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-08-07 | Sell | 106,322 | $126.41 | 13,440,164 |
|
Xencor Inc XNCR
Common Stock
|
2025-06-16 | Sell | 3,173 | $9.22 | 29,255 |
|
Xencor Inc XNCR
Common Stock
|
2025-06-12 | Grant | 13,686 | $0.00 | |
|
Xencor Inc XNCR
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 27,372 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-05-27 | Sell | 9,613 | $120.38 | 1,157,213 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2025-05-21 | Grant | 6,610 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-13 | Option exercise | 5,603 | $0.00 | |
| showing 20 of 190 most recent transactions | |||||